Safety and Efficacy of Early Second Infusion of Axi-cel Based on ctDNA for R/R Large B - Cell Lymphoma
NCT06902012
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Relapsed/Refractory Diffuse Large B-cell Lymphoma
Interventions
DRUG:
Infusion of Axicabtagene Ciloleucel
Sponsor
Zhujiang Hospital